(3S,4R,6S)-6-[(3S,4R,6R)-6-[(3S,4R,6R)-6-[[(3S,5R,8R,9S,10S,12R,13S,14S,17S)-12,14-dihydroxy-17-(hydroxymethyl)-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2-methyloxan-3-yl]oxy-2-methyloxane-3,4-diol

C38H64O13 — CID 140635280

IUPAC(3S,4R,6S)-6-[(3S,4R,6R)-6-[(3S,4R,6R)-6-[[(3S,5R,8R,9S,10S,12R,13S,14S,17S)-12,14-dihydroxy-17-(hydroxymethyl)-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2-methyloxan-3-yl]oxy-2-methyloxane-3,4-diol
SMILESCC1O[C@@H](O[C@@H]2C(C)O[C@H](O[C@@H]3C(C)O[C@@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]5(C)[C@@H](CO)CC[C@]65O)C4)C[C@H]3O)C[C@H]2O)C[C@@H](O)[C@@H]1O
InChIInChI=1S/C38H64O13/c1-18-33(44)26(40)14-31(46-18)50-35-20(3)48-32(16-28(35)42)51-34-19(2)47-30(15-27(34)41)49-23-9-10-36(4)21(12-23)6-7-24-25(36)13-29(43)37(5)22(17-39)8-11-38(24,37)45/h18-35,39-45H,6-17H2,1-5H3/t18?,19?,20?,21-,22-,23+,24-,25+,26-,27-,28-,29-,30+,31+,32-,33-,34-,35-,36+,37+,38+/m1/s1
InChIKeyYNZNEZCNPYNSAF-MFHIBVPNSA-N
MW728.92 g/mol
LogP1.73
Rot. Bonds7

About (3S,4R,6S)-6-[(3S,4R,6R)-6-[(3S,4R,6R)-6-[[(3S,5R,8R,9S,10S,12R,13S,14S,17S)-12,14-dihydroxy-17-(hydroxymethyl)-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2-methyloxan-3-yl]oxy-2-methyloxane-3,4-diol

(3S,4R,6S)-6-[(3S,4R,6R)-6-[(3S,4R,6R)-6-[[(3S,5R,8R,9S,10S,12R,13S,14S,17S)-12,14-dihydroxy-17-(hydroxymethyl)-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2-methyloxan-3-yl]oxy-2-methyloxane-3,4-diol (PubChem CID 140635280) has the molecular formula C38H64O13 and a molecular weight of 728.92 g/mol. Its IUPAC name is (3S,4R,6S)-6-[(3S,4R,6R)-6-[(3S,4R,6R)-6-[[(3S,5R,8R,9S,10S,12R,13S,14S,17S)-12,14-dihydroxy-17-(hydroxymethyl)-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2-methyloxan-3-yl]oxy-2-methyloxane-3,4-diol.

Molecular Properties

Compound Name(3S,4R,6S)-6-[(3S,4R,6R)-6-[(3S,4R,6R)-6-[[(3S,5R,8R,9S,10S,12R,13S,14S,17S)-12,14-dihydroxy-17-(hydroxymethyl)-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2-methyloxan-3-yl]oxy-2-methyloxane-3,4-diol
PubChem CID140635280
Molecular FormulaC38H64O13
Molecular Weight728.92 g/mol
Exact Mass728.43
IUPAC Name(3S,4R,6S)-6-[(3S,4R,6R)-6-[(3S,4R,6R)-6-[[(3S,5R,8R,9S,10S,12R,13S,14S,17S)-12,14-dihydroxy-17-(hydroxymethyl)-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2-methyloxan-3-yl]oxy-2-methyloxane-3,4-diol
SMILESCC1O[C@@H](O[C@@H]2C(C)O[C@H](O[C@@H]3C(C)O[C@@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]5(C)[C@@H](CO)CC[C@]65O)C4)C[C@H]3O)C[C@H]2O)C[C@@H](O)[C@@H]1O
InChIInChI=1S/C38H64O13/c1-18-33(44)26(40)14-31(46-18)50-35-20(3)48-32(16-28(35)42)51-34-19(2)47-30(15-27(34)41)49-23-9-10-36(4)21(12-23)6-7-24-25(36)13-29(43)37(5)22(17-39)8-11-38(24,37)45/h18-35,39-45H,6-17H2,1-5H3/t18?,19?,20?,21-,22-,23+,24-,25+,26-,27-,28-,29-,30+,31+,32-,33-,34-,35-,36+,37+,38+/m1/s1
InChIKeyYNZNEZCNPYNSAF-MFHIBVPNSA-N
XLogP1.73
TPSA196.99 Ų
H-Bond Donors7
H-Bond Acceptors13
Rotatable Bonds7
Heavy Atoms51
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500728.92
LogP ≤ 51.73
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'saponine_derivative', 'substructure': 'N/A'}

Analyze (3S,4R,6S)-6-[(3S,4R,6R)-6-[(3S,4R,6R)-6-[[(3S,5R,8R,9S,10S,12R,13S,14S,17S)-12,14-dihydroxy-17-(hydroxymethyl)-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2-methyloxan-3-yl]oxy-2-methyloxane-3,4-diol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3S,4R,6S)-6-[(3S,4R,6R)-6-[(3S,4R,6R)-6-[[(3S,5R,8R,9S,10S,12R,13S,14S,17S)-12,14-dihydroxy-17-(hydroxymethyl)-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2-methyloxan-3-yl]oxy-2-methyloxane-3,4-diol?
The IUPAC name of (3S,4R,6S)-6-[(3S,4R,6R)-6-[(3S,4R,6R)-6-[[(3S,5R,8R,9S,10S,12R,13S,14S,17S)-12,14-dihydroxy-17-(hydroxymethyl)-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2-methyloxan-3-yl]oxy-2-methyloxane-3,4-diol (CID 140635280) is (3S,4R,6S)-6-[(3S,4R,6R)-6-[(3S,4R,6R)-6-[[(3S,5R,8R,9S,10S,12R,13S,14S,17S)-12,14-dihydroxy-17-(hydroxymethyl)-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2-methyloxan-3-yl]oxy-2-methyloxane-3,4-diol.
What is the SMILES notation for (3S,4R,6S)-6-[(3S,4R,6R)-6-[(3S,4R,6R)-6-[[(3S,5R,8R,9S,10S,12R,13S,14S,17S)-12,14-dihydroxy-17-(hydroxymethyl)-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2-methyloxan-3-yl]oxy-2-methyloxane-3,4-diol?
The canonical SMILES for (3S,4R,6S)-6-[(3S,4R,6R)-6-[(3S,4R,6R)-6-[[(3S,5R,8R,9S,10S,12R,13S,14S,17S)-12,14-dihydroxy-17-(hydroxymethyl)-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2-methyloxan-3-yl]oxy-2-methyloxane-3,4-diol is CC1O[C@@H](O[C@@H]2C(C)O[C@H](O[C@@H]3C(C)O[C@@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]5(C)[C@@H](CO)CC[C@]65O)C4)C[C@H]3O)C[C@H]2O)C[C@@H](O)[C@@H]1O.
What is the InChIKey of (3S,4R,6S)-6-[(3S,4R,6R)-6-[(3S,4R,6R)-6-[[(3S,5R,8R,9S,10S,12R,13S,14S,17S)-12,14-dihydroxy-17-(hydroxymethyl)-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2-methyloxan-3-yl]oxy-2-methyloxane-3,4-diol?
The InChIKey is YNZNEZCNPYNSAF-MFHIBVPNSA-N. The full InChI is InChI=1S/C38H64O13/c1-18-33(44)26(40)14-31(46-18)50-35-20(3)48-32(16-28(35)42)51-34-19(2)47-30(15-27(34)41)49-23-9-10-36(4)21(12-23)6-7-24-25(36)13-29(43)37(5)22(17-39)8-11-38(24,37)45/h18-35,39-45H,6-17H2,1-5H3/t18?,19?,20?,21-,22-,23+,24-,25+,26-,27-,28-,29-,30+,31+,32-,33-,34-,35-,36+,37+,38+/m1/s1.
What are the key properties of (3S,4R,6S)-6-[(3S,4R,6R)-6-[(3S,4R,6R)-6-[[(3S,5R,8R,9S,10S,12R,13S,14S,17S)-12,14-dihydroxy-17-(hydroxymethyl)-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2-methyloxan-3-yl]oxy-2-methyloxane-3,4-diol?
(3S,4R,6S)-6-[(3S,4R,6R)-6-[(3S,4R,6R)-6-[[(3S,5R,8R,9S,10S,12R,13S,14S,17S)-12,14-dihydroxy-17-(hydroxymethyl)-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2-methyloxan-3-yl]oxy-2-methyloxane-3,4-diol has a molecular weight of 728.92 g/mol, XLogP of 1.73, 7 rotatable bonds, 7 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for (3S,4R,6S)-6-[(3S,4R,6R)-6-[(3S,4R,6R)-6-[[(3S,5R,8R,9S,10S,12R,13S,14S,17S)-12,14-dihydroxy-17-(hydroxymethyl)-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2-methyloxan-3-yl]oxy-2-methyloxane-3,4-diol is sourced from PubChem (CID 140635280), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).